JP2013040189A5 - - Google Patents

Download PDF

Info

Publication number
JP2013040189A5
JP2013040189A5 JP2012225014A JP2012225014A JP2013040189A5 JP 2013040189 A5 JP2013040189 A5 JP 2013040189A5 JP 2012225014 A JP2012225014 A JP 2012225014A JP 2012225014 A JP2012225014 A JP 2012225014A JP 2013040189 A5 JP2013040189 A5 JP 2013040189A5
Authority
JP
Japan
Prior art keywords
chemical
compound selected
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012225014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013040189A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012225014A priority Critical patent/JP2013040189A/ja
Priority claimed from JP2012225014A external-priority patent/JP2013040189A/ja
Publication of JP2013040189A publication Critical patent/JP2013040189A/ja
Publication of JP2013040189A5 publication Critical patent/JP2013040189A5/ja
Pending legal-status Critical Current

Links

JP2012225014A 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法 Pending JP2013040189A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012225014A JP2013040189A (ja) 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010133486 2010-06-11
JP2010133486 2010-06-11
JP2012225014A JP2013040189A (ja) 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012519401A Division JP5113958B2 (ja) 2010-06-11 2011-06-07 薬剤多量体微粒子及びその製造方法

Publications (2)

Publication Number Publication Date
JP2013040189A JP2013040189A (ja) 2013-02-28
JP2013040189A5 true JP2013040189A5 (enExample) 2014-07-24

Family

ID=45098106

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012519401A Active JP5113958B2 (ja) 2010-06-11 2011-06-07 薬剤多量体微粒子及びその製造方法
JP2012225014A Pending JP2013040189A (ja) 2010-06-11 2012-10-10 薬剤多量体微粒子及びその製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012519401A Active JP5113958B2 (ja) 2010-06-11 2011-06-07 薬剤多量体微粒子及びその製造方法

Country Status (5)

Country Link
US (1) US20130096097A1 (enExample)
EP (1) EP2586463B1 (enExample)
JP (2) JP5113958B2 (enExample)
CN (1) CN103068404B (enExample)
WO (1) WO2011155501A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150119388A1 (en) * 2012-06-15 2015-04-30 The Children's Hospital Philadelphia Novel pro- and codrug derivatives for nanoparticle delivery of select anticancer agents formed using rapidly cleavable phenolic ester bridges
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
JP7626491B2 (ja) * 2021-03-12 2025-02-04 国立研究開発法人科学技術振興機構 Sn-38誘導体、当該誘導体を含むナノ粒子、医薬及び当該ナノ粒子の製造方法
CN120322442A (zh) * 2022-12-09 2025-07-15 国立研究开发法人科学技术振兴机构 化合物、纳米粒子、医药、及纳米粒子的制造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JP2723200B2 (ja) 1992-09-07 1998-03-09 均 笠井 非線形光学用有機微結晶の製法
ES2262223T3 (es) 1997-02-14 2006-11-16 Bionumerik Pharmaceuticals, Inc. Derivados de camptotecina altamente lipofilos.
US6011042A (en) 1997-10-10 2000-01-04 Enzon, Inc. Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
AU2003253890A1 (en) * 2002-07-12 2004-02-02 Biomarin Pharmaceutical Inc. The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
US20070041093A1 (en) 2005-08-22 2007-02-22 Stuart Bard Projector screen for use in a lighted room
TW200731991A (en) * 2005-12-20 2007-09-01 Sonus Pharma Inc Lipophilic di(anticancer drug) compounds, compositions and related methods
US8367065B2 (en) 2006-09-15 2013-02-05 Enzon Pharmaceuticals, Inc. Targeted polymeric prodrugs containing multifunctional linkers
CN101541332A (zh) 2006-09-15 2009-09-23 安佐制药股份有限公司 含多官能连接基的靶向聚合物前药
GB0714223D0 (en) * 2007-07-20 2007-08-29 Fujifilm Mfg Europe Bv Preparation of fine particles
CL2008003699A1 (es) * 2007-12-13 2009-10-09 Takeda Pharmaceuticals Co Nanopartícula que comprende pioglitazona y un polímero biocompatible, preparación farmacéutica que la contiene; stent (endoprótesis vascular) que la porta; y su uso en la profilaxis o tratamiento de enfermedades arterioescleróticas.
WO2010053101A1 (ja) * 2008-11-06 2010-05-14 国立大学法人東北大学 眼内移行性の高い点眼剤および蛍光イメージング剤ならびにそれらの製造方法
CN101628919B (zh) * 2009-08-20 2011-11-23 浙江大学 喜树碱及其衍生物的自乳化药物前体及其应用

Similar Documents

Publication Publication Date Title
JP2012255926A5 (enExample)
JP2012107057A5 (enExample)
JP2011102971A5 (enExample)
JP2013033060A5 (enExample)
JP2013541578A5 (enExample)
JP2013521563A5 (enExample)
JP2012111758A5 (enExample)
JP2011093937A5 (enExample)
JP2013539946A5 (enExample)
JP2013531034A5 (enExample)
JP2012204203A5 (enExample)
JP2014505137A5 (enExample)
JP2012031285A5 (enExample)
JP2013064178A5 (enExample)
JP2012098270A5 (enExample)
JP2012193264A5 (enExample)
JP2012190699A5 (enExample)
JP2013145868A5 (enExample)
JP2011233516A5 (enExample)
JP2014520786A5 (enExample)
JP2011175463A5 (enExample)
JP2013016377A5 (enExample)
JP2012115928A5 (enExample)
JP2014507463A5 (enExample)
JP2013236836A5 (enExample)